Statements of Cash Flows - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Statement of Cash Flows [Abstract]
Net income (loss)		$ 63	$ (20)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Interest credited to policyholders’ account balances		23	19
Policy charges and fee income		(61)	(56)
Net derivative (gains) losses		(6)	8
Investment (gains) losses, net		5	1
Realized and unrealized (gains) losses on trading securities		2	0
Non-cash long-term incentive compensation expense		1	1
Amortization and depreciation		13	10
Remeasurement of liability for future policy benefits		(1)	(1)
Change in Market Risk Benefits		0	(5)
Changes in:
Reinsurance recoverable		(9)	1
Capitalization of deferred policy acquisition costs		(76)	(26)
Future policy benefits		9	9
Current and deferred income taxes (1)	[1]	(72)	(7)
Other, net		89	74
Net cash provided by (used in) operating activities		(20)	8
Proceeds from the sale/maturity/prepayment of:
Fixed maturities, available-for-sale		58	50
Short-term investments		0	(2)
Payment for the purchase/origination of:
Fixed maturities, available-for-sale		(963)	(119)
Trading account securities		(2)
Other			(1)
Cash settlements related to derivative instruments, net		(96)	(24)
Other, net		(6)	0
Net cash provided by (used in) investing activities		(1,009)	(96)
Cash flows from financing activities:
Deposits		1,202	187
Withdrawals		(13)	(20)
Transfer (to) from Separate Accounts		(15)	(59)
Change in collateralized pledged liabilities		96	(1)
Other, net		0	(1)
Net cash provided by (used in) financing activities		1,270	106
Change in cash and cash equivalents		241	18
Cash and cash equivalents, beginning of year		294	127
Cash and cash equivalents, end of year		$ 535	$ 145

[1] For the period ended March 31, 2023 includes a release of $69 million deferred tax valuation allowance. Refer to Note 10 of these Consolidated Financial Statements.